FDA inspects Particle Technology Group in Downers Grove on Feb. 20

Benjamin D. Moncarz Chief Financial Officer - FDA
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
By R. U. Cooper

The Food and Drug Administration (FDA) conducted an inspection at Particle Technology Group, LLC in Downers Grove on Feb. 20, according to information posted on the FDA's website.

The assessment reviewed the following areas:

  • Drug Quality Assurance
  • Monitoring of Marketed Animal Drugs, Feed, and Devices

The final report concluded that no corrective action was required for Particle Technology Group, LLC relating to its management operations.

The FDA regularly checks facilities throughout the country to confirm that workplaces and products comply with FDA-regulated laws and standards designed to safeguard public health. Inspection outcomes are made publicly available.

The agency states on its website that its primary duties include regulation and oversight of human and animal pharmaceuticals, biologics, medical devices and tobacco products to ensure safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.